Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Comprehensive Loss (unaudited)

v3.10.0.1
Condensed Consolidated Statements of Comprehensive Loss (unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Income Statement [Abstract]        
Revenue $ 38
Cost of revenue 56
Gross loss (18)
Operating expenses:        
Research and development 1,770 965 4,357 2,701
Sales and marketing 1,215 614 2,945 1,603
General and administrative 2,145 2,414 6,021 4,907
Total operating expenses 5,130 3,993 13,323 9,211
Operating loss (5,130) (3,993) (13,341) (9,211)
Warrant expense (3,156)
Loss on change in fair value of contingent royalty obligation (85) (72) (244) (207)
Finance income, net 44 73
Reversal of registration rights expense 900
Foreign currency gain (loss) 1 (22) (9)
Loss before income taxes (5,170) (3,165) (16,690) (9,427)
Income tax expense
Net loss $ (5,170) $ (3,165) $ (16,690) $ (9,427)
Basic and diluted loss per common share (in dollars per share) $ (0.33) $ (0.30) $ (1.13) $ (0.92)
Weighted average number of common shares outstanding, basic and diluted (in shares) 15,680,750 10,489,822 14,782,285 10,288,895